We are LOTTE Biologics! A new company, built on 80 years of tradition!
We embody our core values of being Inspired by Science, Embracing Diversity, Fostering Talent, and Connecting Lives. Our mission is to be the most trusted partner in the industry, with high standards of quality and continuous innovation, to reliably deliver benefits for patients worldwide.
We deliver therapies that make a Healthier World!
To help us meet our mission LOTTE Biologics is in need of a Principal Scientist, Process Microbiologist in the Manufacturing Science & Technology (MSAT) department to lead the overall process microbial control strategy for various customer processes. The Principal Scientist will use scientific understanding of biologics process risks to identify potential bioburden entry points into the production process, assess the needs for bioburden control at different production process steps, confirm performance is expected under process conditions, and monitor the process to confirm maintenance of bioburden control. The incumbent will collaborate with Process Development, MSAT, Manufacturing, Supply Chain, Quality Control (QC), Microbiology Control, and Aseptic Quality Operations (AQO), Quality Assurance (QA), as well as Facilities and Engineering to design the bioburden control process map. The Principal Scientist will be responsible for identifying risks and severity levels to inform planning of process raw material selection, process elements and conditions, establishment of process alert/action levels, and selection of appropriate monitoring and detection methods. Additionally, the Principal Scientist is expected to remain current on industry trends and ICH guidelines, while also directly interacting with customers and health authority agencies to communicate the process control strategy elements.
This position requires up to 10% of domestic and/or international travel.
East Syracuse, NY
We believe that women, people of color, veterans and LGBTQ communities must participate in the work we do, so we strongly encourage applications from people with these identities or who are members of underrepresented communities. If this is the work that you want to do in a culture of inclusion and excellence with the goal of making our world to be a healthier place, then please apply today!
LOTTE BIOLOGICS was established in 2022, and is headquartered in Seoul, South Korea. LOTTE BIOLOGICS entered the biologics CDMO business after acquiring Bristol Myers Squibb’s Syracuse biologics drug substance manufacturing site, as of January 1, 2023!
The newly established organization aims to become a Global Top 10 CDMO company in the biopharmaceutical industry. With initial operations in 1948 in Japan, LOTTE has grown to become the fifth-largest conglomerate corporation in South Korea. LOTTE has various business units, including petro/fine chemicals, food, retail, hotels, electronics, construction, and IT. LOTTE has 30+ global locations across the US, Europe, and Asia.
An Equal Opportunity Employer
We do not discriminate based on race, color, religion, national origin, sex, age, disability, genetic information, or any other status protected by law or regulation. It is our intention that all qualified applicants are given equal opportunity and that selection decisions be based on job-related factors.